J. Warren Huff

2020

In 2020, J. Warren Huff earned a total compensation of $6.4M as Chief Executive Officer, President and Chairman of the Board at REATA PHARMACEUTICALS, a 15% increase compared to previous year.

Compensation breakdown

Bonus$413,660
Option Awards$5,341,070
Salary$636,400
Other$5,000
Total$6,396,130

Huff received $5.3M in option awards, accounting for 84% of the total pay in 2020.

Huff also received $413.7K in bonus, $636.4K in salary and $5K in other compensation.

Rankings

In 2020, J. Warren Huff's compensation ranked 1,595th out of 13,090 executives tracked by ExecPay. In other words, Huff earned more than 87.8% of executives.

ClassificationRankingPercentile
All
1,595
out of 13,090
88th
Division
Manufacturing
598
out of 5,621
89th
Major group
Chemicals And Allied Products
214
out of 2,254
91st
Industry group
Drugs
178
out of 1,954
91st
Industry
Pharmaceutical Preparations
123
out of 1,459
92nd

Pay ratio

J. Warren Huff's Pay$6,396,130
Median Employee's Pay$568,580
Pay Ratio

11

to 1

In 2020, the annual total compensation of J. Warren Huff was $6,396,130.

The annual total compensation of the median employee at REATA PHARMACEUTICALS was $568,580.

The ratio of J. Warren Huff's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on April 30, 2021.

Huff's colleagues

We found four more compensation records of executives who worked with J. Warren Huff at REATA PHARMACEUTICALS in 2020.

2020

Manmeet Soni

REATA PHARMACEUTICALS

Chief Financial Officer

2020

Colin Meyer

REATA PHARMACEUTICALS

Chief Research and Development Officer and Executive Vice President

2020

Michael Wortley

REATA PHARMACEUTICALS

Chief Legal Officer

2020

Dawn Bir

REATA PHARMACEUTICALS

Chief Commercial Officer and Executive Vice President

News

In-depth

You may also like